Università di Ferrara - Tecnopolo Universtità di Ferrara Universtità di Ferrara
 

     
 

Tariffario

Moduli

 
     
[ Italiano | English ]

Pubblicazioni

  • Tisato V, Zauli G, Gianesini S, Menegatti E, Brunelli L, Manfredini R, Zamboni P, Secchiero P (2014) Modulation of circulating cytokine-chemokine profile in patients affected by chronic venous insufficiency undergoing surgical hemodynamic correction. J Immunol Res 2014:473765. PubMed
  • Voltan R, Zauli G, Rizzo P, Fucili A, Pannella M, Marci R, Tisato V, Ferrari R, Secchiero P (2014) In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure. Mediators Inflamm. 2014:257081. PubMed
  • Voltan R, Secchiero P, Ruozi B, Forni F, Agostinis C, Caruso L, Vandelli MA, Zauli G (2013) Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. Clin. Cancer Res. 19:3871-80. PubMed
  • Secchiero P, Rimondi E, di Iasio MG, Agnoletto C, Melloni E, Volpi I, Zauli G (2013) C-Reactive Protein Downregulates TRAIL Expression in Human Peripheral Monocytes via an Egr-1-Dependent Pathway. Clin. Cancer Res. 19:1949-59. PubMed
  • Tisato V, Zauli G, Voltan R, Gianesini S, di Iasio MG, Volpi I, Fiorentini G, Zamboni P, Secchiero P (2012) Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. PLoS ONE 7:e39543. PubMed
  • Secchiero P, Melloni E, Voltan R, Norcio A, Celeghini C, Zauli G (2012) MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. Br. J. Haematol. 157:510-4. PubMed
  • di Iasio MG, Addobbati R, Radillo O, Voltan R (2012) Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples. Invest New Drugs 30:1761-5. PubMed
  • Voltan R, di Iasio MG, Bosco R, Valeri N, Pekarski Y, Tiribelli M, Secchiero P, Zauli G (2011) Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells. Clin. Cancer Res. 17:5649-55. PubMed
  • Zauli G, Voltan R, di Iasio MG, Bosco R, Melloni E, Sana ME, Secchiero P (2011) miR-34a Induces the Downregulation of Both E2F1 and B-Myb Oncogenes in Leukemic Cells. Clin. Cancer Res. 17:2712-24. PubMed
  • Zauli G, Voltan R, Bosco R, Melloni E, Marmiroli S, Rigolin GM, Cuneo A, Secchiero P (2011) Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53 wild-type and p53 mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. Clin. Cancer Res. 17:762-70. PubMed
  • Corallini F, Celeghini C, Rimondi E, di Iasio MG, Gonelli A, Secchiero P, Zauli G (2011) Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. J. Cell. Physiol. 226:2279-86. PubMed
  • Voltan R, Celeghini C, Melloni E, Secchiero P, Zauli G (2010) Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. Br. J. Haematol. 148:957-61. PubMed
  • Corallini F, Secchiero P, Beltrami AP, Cesselli D, Puppato E, Ferrari R, Beltrami CA, Zauli G (2010) TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. Cell. Mol. Life Sci. 67:1307-14. PubMed
  • Bosco R, Rabusin M, Voltan R, Celeghini C, Corallini F, Capitani S, Secchiero P (2010) Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells. Invest New Drugs 30:417-22. PubMed
  • Secchiero P, Melloni E, Corallini F, Beltrami AP, Alviano F, Milani D, D'Aurizio F, di Iasio MG, Cesselli D, Bagnara GP, Zauli G (2008) Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells. Stem Cells 26:2955-63. PubMed
  • Secchiero P, Melloni E, di Iasio MG, Tiribelli M, Rimondi E, Corallini F, Gattei V, Zauli G (2009) Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism. Blood 113:4300-8. PubMed
  • Secchiero P, di Iasio MG, Melloni E, Voltan R, Celeghini C, Tiribelli M, Dal Bo M, Gattei V, Zauli G (2010) The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia. Leukemia 24:480-3. PubMed
  • Secchiero P, Voltan R, di Iasio MG, Melloni E, Tiribelli M, Zauli G (2010) The oncogene DEK promotes leukemic cell survival and is downregulated by both Nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells. Clin. Cancer Res. 16:1824-33. PubMed
 
ASTER Por-Fesr Universtità di Ferrara